Increase of Serum Ferritin Levels During HCV Triple Therapy With Telaprevir, PEG-Interferon ALPHA-2A and Ribavirin Predicts Rrvr

被引：0
|
作者：
Zopf, Steffen
Janisch, Florian
Siebler, Juergen
Neurath, Markus F.
Janisch, Hans-Dieter
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：S980 / S980
页数：1
相关论文
共 50 条
  • [1] Increase of Serum Ferritin as a Marker for the rRVR under antiviral Triple Therapy with Telaprevir, PEG-Interferon alfa-2a and Ribavirin for chronic Hepatitis C
    Zopf, S.
    Janisch, F.
    Siebler, J.
    Neurath, M.
    Janisch, H.
    INTERNIST, 2013, 54 : 29 - 29
  • [2] EFFICACY AND SAFETY OF SIMEPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY IN PATIENTS WITH HCV GENOTYPE 1-COMPARISON WITH TELAPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY AND PEG-INTERFERON/RIBAVIRIN THERAPY
    Nakajima, T.
    Kimura, M.
    Arakawa, T.
    Kuwata, Y.
    Ozeki, I.
    Sato, T.
    Ohmura, T.
    Hige, S.
    Karino, Y.
    Toyota, J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S494 - S494
  • [3] Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin
    Andriulli, A.
    Cursaro, C.
    Cozzolongo, R.
    Iacobellis, A.
    Valvano, M. R.
    Mangia, A.
    Minerva, N.
    Bacca, D.
    Stanzione, M.
    Scuteri, A.
    Montalto, G.
    Andreone, P.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (01) : 28 - 35
  • [4] The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection
    Garbuglia, Anna Rosa
    Lionetti, Raffaella
    Lapa, Daniele
    Taibi, Chiara
    Visco-Comandini, Ubaldo
    Montalbano, Marzia
    D'Offizi, Gianpiero
    Castiglione, Filippo
    Capobianchi, Maria Rosaria
    Paci, Paola
    JOURNAL OF CLINICAL VIROLOGY, 2015, 69 : 68 - 73
  • [5] Peg-Interferon Alpha-2a versus Peg-Interferon Alpha-2b in Nonresponders with HCV Active Chronic Hepatitis: A Pilot Study
    Scotto, Gaetano
    Fazio, Vincenzina
    Fornabaio, Chiara
    Tartaglia, Alessandra
    Di Tullio, Rocco
    Saracino, Annalisa
    Angarano, Gioacchino
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2008, 28 (10): : 623 - 629
  • [6] Ribavirin dose reduction during telaprevir/ribavirin/peg-interferon therapy overcomes the effect of the ITPA gene polymorphism
    Akamatsu, S.
    Hayes, C. N.
    Tsuge, M.
    Murakami, E.
    Hiraga, N.
    Abe, H.
    Miki, D.
    Imamura, M.
    Ochi, H.
    Chayama, K.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (02) : 166 - 174
  • [7] Influence of HCV Genotype 1 Subtypes on the Virus Response to PEG Interferon Alpha-2a Plus Ribavirin Therapy
    Nicot, F.
    Alric, L.
    Barange, K.
    Metivier, S.
    Dramard, J. M.
    Combis, J. M.
    Castan, B.
    Meurisse, J. J.
    Payen, J. L.
    Garipuy, D.
    Desmorat, H.
    Peron, J. M.
    Thebault, S.
    Morin, T.
    Renou, C.
    Barel, P.
    Guerin, B.
    Imbert, Y.
    Sire, S.
    Saune, K.
    Chatelut, E.
    Izopet, J.
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (03) : 437 - 444
  • [8] COST-EFFECTIVENESS ANALYSIS OF PEG-INTERFERON ALPHA-2A PLUS RIBAVIRIN VERSUS CONVENTIONAL INTERFERON ALPHA-2A PLUS RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C IN CHINA
    Chen, W.
    Wei, L.
    VALUE IN HEALTH, 2011, 14 (07) : A280 - A280
  • [9] Influence of serum ribavirin concentration and hemoglobin level on rapid virological reponse to telaprevir or to boceprevir Peg-Interferon ribavirin retreatment in HCV genotype 1 patients with severe liver fibrosis and a previous failure to Peg-Interferon and ribavirin treatment
    Alric, Laurent
    Bonnet, Delphine
    Palacin, Anais
    Thebault, Sophie
    Fooladi, Atoussa
    Sigur, Nicolas
    Nicot, Florence
    Abravanel, Florence
    Izopet, Jacques
    HEPATOLOGY, 2012, 56 : 1008A - 1008A
  • [10] VERY-EARLY VIRAL RESPONSE (WEEK-1) TO TRIPLE THERAPY WITH TELAPREVIR, PEG-INTERFERON AND RIBAVIRIN PREDICTS EXTENDED-RVR AND TREATMENT OUTCOMES IN PATIENTS WITH HCV GENOTYPE 1
    Takaguchi, K.
    Toyota, H.
    Seno, T.
    Baba, N.
    Nagano, T.
    Kumada, T.
    Kato, K.
    Shimada, N.
    Ide, T.
    Sata, M.
    Tsubota, A.
    Izumi, N.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S204 - S205
12345